PASCAL Laser Versus ETDRS Laser Associated With Intravitreal Ranibizumab (IVR) Versus Only IVR for Proliferative Diabetic Retinopathy
Condition(s):Proliferative Diabetic RetinopathyLast Updated:December 9, 2013Unknown status
Hide Studies Not Open or Pending
Condition(s):Proliferative Diabetic RetinopathyLast Updated:December 9, 2013Unknown status
Condition(s):AMDLast Updated:July 20, 2018Completed
Condition(s):Macular Edema; Retinal Vein OcclusionLast Updated:April 23, 2021Terminated
Condition(s):Age-related Macular DegenerationLast Updated:November 14, 2013Completed
Condition(s):Cystoid Macular EdemaLast Updated:May 28, 2012Completed
Condition(s):Polypoidal Chorodial Vasculopathy; Age Related Macular DegenerationLast Updated:November 1, 2012Unknown status
Condition(s):Neovascular Age-Related Macular DegenerationLast Updated:September 24, 2018Completed
Condition(s):Central Retinal Vein OcclusionLast Updated:September 12, 2012Completed
Condition(s):Age Related Macular Degeneration; Intravitreal Injections; Diabetic Macular EdemaLast Updated:January 17, 2023Recruiting
Condition(s):Age-Related Macular DegenerationLast Updated:April 9, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.